4.7 Article

Genome-scale metabolic modelling of the human gut microbiome reveals changes in the glyoxylate and dicarboxylate metabolism in metabolic disorders

期刊

ISCIENCE
卷 25, 期 7, 页码 -

出版社

CELL PRESS
DOI: 10.1016/j.isci.2022.104513

关键词

-

资金

  1. Engineering and Physical Sciences Research Council (EPSRC) [EP/S001301/1]
  2. Biotechnology Biological Sciences Research Council (BBSRC) [BB/M009513/1]
  3. Swedish National Infrastructure for Computing at SNIC through Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) [SNIC 2020-5-222, SNIC 2019/3-226, SNIC 2020/6-153, SNIC 2021/5-248, SNIC 2021/6-242, SNIC 2021/6-89]

向作者/读者索取更多资源

The human gut microbiome is associated with metabolic disorders such as obesity, type 2 diabetes, and atherosclerosis. The study investigated the role of gut bacteria in metabolic diseases using metagenomics data and metabolic modeling. The modeling predicted changes in glutamate consumption and the production of ammonia, arginine, and proline in gut bacteria common across the disorders. The study also found that tartrate dehydrogenase is enriched in the disorders and an increased tartrate metabolism is associated with certain metabolites in healthy obese individuals.
The human gut microbiome has been associated with metabolic disorders including obesity, type 2 diabetes, and atherosclerosis. Understanding the contri-bution of microbiome metabolic changes is important for elucidating the role of gut bacteria in regulating metabolism. We used available metagenomics data from these metabolic disorders, together with genome-scale metabolic modeling of key bacteria in the individual and community-level to investigate the mecha-nistic role of the gut microbiome in metabolic diseases. Modeling predicted increased levels of glutamate consumption along with the production of ammonia, arginine, and proline in gut bacteria common across the disorders. Abundance profiles and network-dependent analysis identified the enrichment of tartrate dehydrogenase in the disorders. Moreover, independent plasma metabolite levels showed associations between metabolites including proline and tyrosine and an increased tartrate metabolism in healthy obese individuals. We, therefore, propose that an increased tartrate metabolism could be a signifi-cant mediator of the microbiome metabolic changes in metabolic disorders.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据